Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort.

about

A case report of remission of refractory membranous nephropathy progressing to stage 4 chronic kidney disease using low-dose rituximab: A long-term follow-up.

P2860

Q55434137-C7D2EA65-86D3-4F64-9203-BB250CDD1117

P2860

Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort.

Item

http://www.wikidata.org/entity/Q49921840

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort.

@en

Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort.

@nl

type

Item

label

Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort.

@en

Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort.

@nl

prefLabel

Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort.

@en

Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort.

@nl

P1476

Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort.

@en

P2093

Fang Wang

http://www.w3.org/2001/XMLSchema#string

Fu-de Zhou

http://www.w3.org/2001/XMLSchema#string

Gang Liu

http://www.w3.org/2001/XMLSchema#string

Li-Qiang Meng

http://www.w3.org/2001/XMLSchema#string

Ming-Hui Zhao

http://www.w3.org/2001/XMLSchema#string

Xin Wang

http://www.w3.org/2001/XMLSchema#string

Xu-Yang Cheng

http://www.w3.org/2001/XMLSchema#string

Yi-Miao Zhang

http://www.w3.org/2001/XMLSchema#string

Zhen Qu

http://www.w3.org/2001/XMLSchema#string

P2860

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

Rituximab therapy in idiopathic membranous nephropathy: a 2-year study.

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy

Rituximab in idiopathic membranous nephropathy.

Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients

Membranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab.

The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient.

Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population.

P304

1558-1563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFX295

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zhao Cui

P577

2017-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29149305

http://www.w3.org/2001/XMLSchema#string

Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort.

about

P2860

P2860

Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698